This is generally mild and self-limiting, but if headaches persist beyond the first week or are significant, stopping use and consulting a doctor is the sensible approach rather than continuing through discomfort
Newsletter Signup - Under Article / In Page "*" indicates required fields Glucagon-like peptide 1 (GLP-1) agonists have proven their therapeutic mettle in treating metabolic diseases like diabetes and obesity, and now, researchers are studying their effects on cardiovascular disease
Who is an ideal candidate for Semaglutide therapy
A common approach is to eat at your full target on training days and reduce by 200-300 calories on sedentary days
However, experts agree that data is still too limited to rule out long-term risks entirely, especially for rare tumor types
This phase is common as the body adapts to semaglutide and begins to respond to its appetite-suppressing effects